ACQUIRED PERFORATING DERMATOSIS

This adverse event was reported 16 times

These drugs are most commonly taken by patients reporting ACQUIRED PERFORATING DERMATOSIS:

# Drug Count
0 CABOZANTINIB 4
1 BEVACIZUMAB 3
2 METFORMIN 3
3 METFORMIN ER 500 MG 3
4 METFORMIN ER 750 MG 3
5 ATEZOLIZUMAB 2
6 ADALIMUMAB 1
7 ADALIMUMAB-AATY 1
8 ADALIMUMAB-ADAZ 1
9 ADALIMUMAB-FKJP 1
See all common drugs associated with ACQUIRED PERFORATING DERMATOSIS

ACQUIRED PERFORATING DERMATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMIVANTAMAB-VMJW 1 0.0003
1 CABOZANTINIB 4 0.0001
2 ATEZOLIZUMAB 2 0.0001
3 CETUXIMAB 1 0.0000
4 PEMETREXED DISODIUM 1 0.0000
5 BEVACIZUMAB 3 0.0000
6 IPILIMUMAB 1 0.0000
7 ADALIMUMAB-FKJP 1 0.0000
8 ADALIMUMAB-AATY 1 0.0000
9 GEMCITABINE HYDROCHLORIDE 1 0.0000
See all drugs enriched for association with ACQUIRED PERFORATING DERMATOSIS